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Abstract
Background: The phase II detoxification enzymes execute a major protective role against xenobiotics as well as
endogenous toxicants. To understand how xenobiotics regulate phase II enzyme expression, acrylamide was selected as a
model xenobiotic chemical, as it induces a large number and a variety of phase II enzymes, including numerous glutathione
S-transferases (GSTs) in Caenorhabditis elegans.
Methodology/Principal Findings: To begin dissecting genetically xenobiotics response pathways (xrep), 24 independent
mutants of C. elegans that exhibited abnormal GST expression or regulation against acrylamide were isolated by screening
about 3.5610
5 genomes of gst::gfp transgenic strains mutagenized with ethyl methanesulfonate (EMS). Complementation
testing assigned the mutants to four different genes, named xrep-1, -2, -3, and -4. One of the genes, xrep-1, encodes WDR-23,
a nematode homologue of WD repeat-containing protein WDR23. Loss-of-function mutations in xrep-1 mutants resulted in
constitutive expression of many GSTs and other phase II enzymes in the absence of acrylamide, and the wild-type xrep-1
allele carried on a DNA construct successfully cured the mutant phenotype of the constitutive enzyme expression.
Conclusions/Significance: Genetic and cellular characterization of xrep-1 mutants suggest that a large number of GSTs and
other phase II enzymes induced by acrylamide are under negative regulation by XREP-1 (WDR-23), which is likely to be a
functional equivalent of mammalian Keap1 and a regulator of SKN-1, a C. elegans analogue of cap-n-collar Nrf2 (nuclear
factor erythroid 2-related factor 2).
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Introduction
Xenobiotics such as harmful food substances (e.g., acrylamide
and 2-amino-1-methyl-6-phenylimidazol [4,5-b] pyridine), envi-
ronmental pollutants (e.g., heavy metals like mercury and
cadmium), or mycotoxins and exotoxins from contaminating
microorganisms are direct or indirect threats that incur mutagenic,
carcinogenic, teratogenic, endocrine disruptive, or other deleteri-
ous consequences [1–5]. Oxidative processes, such as oxidative
phosphorylation indispensable for aerobic organisms to produce
ATP via respiration, ironically produce highly active free radicals
in the process: these radicals are thought to contribute to cancer,
atherosclerosis, inflammation, hypertension, and diabetes [6].
Against all such exogenous and endogenous toxicants, phase II
enzymes, with glutathione S-transferases (GSTs) as most promi-
nent, are considered to play a major protective role [7–11]. As for
GSTs, we should not dismiss other critical biochemical roles some
GSTs play in such processes as eicosanoid or steroid hormone
biosynthesis and amino acid metabolism [9,12,13].
Acrylamide, now recognized as a prevalent food substance, has
been long known as a neurotoxin for many animals and a potential
carcinogen for humans [1,14]. Previously we reported in the
nematode Caenorhabditis elegans [11] that acrylamide up-regulates a
large number of phase II enzymes such as GSTs and UDP-
glucuronosyl/glucosyl transferases (UGTs) and some phase I
enzymes such as short-chain type dehydrogenases (SDRs).
C. elegans offers many experimental advantages as a model for
understanding diverse aspects of biology, including responses to
xenobiotics [15]. In mammals, acrylamide might be detoxified
mainly by GSTs and excreted in urine [16,17]. Among GSTs that
acrylamide up-regulated more than two-fold, those we studied
displayed spatially varied expression patterns. For all these reasons
we have selected acrylamide as a representative chemical for
xenobiotics exposure.
To dissect genetically a xenobiotics response pathway (xrep)f r o ma
target of xenobiotics to the final destination of phase II enzyme
expression, we isolated xrep gene mutants with abnormal GST
expression or response to acrylamide. Here we report on one of four
genes defined by these mutants, xrep-1, that encodes a WD repeat-
containing protein, a nematode homologue of mammalian WDR23,
and provide genetic and cellular evidence that the gene xrep-1
negatively regulates GSTs and some other phase II enzymes.
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Isolation and mapping of mutants showing abnormal
GST regulation
We used two gst::gfp transgenic animals, MJCU017 and
MJCU047, to screen for mutants abnormally expressing GFP.
MJCU017 and MJCU047, which have the chromosomally-
integrated gst-4::gfp and gst-30::gfp fusion genes, respectively,
emitted no detectable GFP signal in the absence of acrylamide,
but emitted a very strong GFP signal from the whole body when
treated with acrylamide (Fig. 1) [11,18]. Mapping with a set of
conventional marker mutants located both of these fusion genes as
being integrated in linkage group X (data not shown). These
animals were outcrossed at least three times with the wild-type
strain N2.
We mutagenized these transgenic strains with ethyl methane-
sulfonate (EMS) and screened about 3.5610
5 genomes to obtain
24 independent mutants. The mutants were then outcrossed more
than three times with N2 wild type to reduce unwanted mutations.
Complementation testing and linkage analysis assigned 16 of the
mutations defined by these 24 mutants to the same gene on linkage
group (LG) I (chromosome I): all of the 16 mutations were
recessive, and the affected strains constitutively expressed GST in
the whole body without acrylamide. Six, assigned to the same gene
on LG II, were also recessive, and their mutants constitutively
expressed GST in the body-wall muscle and pharynx only after
they had reached the adult stage. Of the remaining two strains,
one mutation on LG IV was dominant, with constitutively
expressed GST throughout the whole body, whereas the other
one, on LG I, was recessive with its mutant expressing no GST
even when treated with acrylamide. We called these genes defined
by the four complementation groups xrep-1, -2, -3, and -4, in the
respective order described above.
The xrep-1 gene is wdr-23
In SNP mapping involving the Hawaiian wild-type strain
CB4856 crossed with the xrep-1(k1007) mutation, one of the 16
xrep-1 alleles, we successfully assigned the gene xrep-1 to the middle
of LG I between the SNP markers F21C3 and T23G11. Of the
total 704 recombinants analyzed, no Hawaiian polymorphism was
identified within the genomic region consisting of the cosmid clone
D2030, indicating that the mutation site was in or near D2030
(Fig. 2a). We amplified 12 genes within the D2030 cosmid with T7
promoter-added primers and synthesized dsRNA for soaking
RNAi. RNAi of the D2030.9 gene performed in MJCU017
resulted in the induction of GST-4 expression without acrylamide
(Fig. S1). Furthermore, the DNA fragment of D2030.9 amplified
from N2 genomic DNA rescued the xrep-1(k1007) mutant
phenotype (data not shown).
D2030.9 encodes WDR-23, a nematode homologue of
WDR23, a member of WD40 repeat-containing proteins, which
are known to exist in yeast through plants and mammals [19]; and
WDR-23 was recently reported to be involved in C. elegans GST-4
expression [20]. Five xrep-1 mutations sequenced so far have
revealed four missense mutations and one nonsense mutation in
the WD repeat domain, suggesting that this domain is important
in the regulation of GST expression by keeping it from being
induced in the absence of acrylamide (Fig. 2b). To avoid
unnecessary confusion, we continue to use the gene name xrep-1
and its corresponding protein name XREP-1 instead of wdr-23
and WDR-23 unless necessary for clarification.
GST-4 expression is not totally but partially regulated by
SKN-1
We reported previously that acrylamide-induced GST-4
expression was partially regulated by the transcription factor
SKN-1 [11]. To examine whether the constitutive GST expression
caused by the xrep-1 mutation was under SKN-1 control, we
performed a series of knockdown experiments by feeding C. elegans
RNAi constructs. As should be expected, the xrep-1(k1007) mutant
constitutively emits a strong GFP signal from the whole body
without acrylamide, and treating it with acrylamide did not further
enhance this signal (Fig. 3). Knockdown of gfp resulted in the
shutdown of both the constitutive and acrylamide-induced GFP
signals except for that in the pharynx as expected (Fig. 3). The skn-
1 knockdown also prevented the constitutive and acrylamide-
induced GST-4 expression except for that in the pharynx and in
Figure 1. The xrep-1(k1007) mutants constitutively express GST-4 and GST-30 in the absence of acrylamide. (a) MJCU017 wild-type xrep-
1(+) animals. Without acrylamide, no GST-4::GFP expression is detected (arrows). (b) MJCU017 wild-type xrep-1(+) animals treated with 500 mg/L
acrylamide for 24 hours at 20uC. GST-4::GFP expression is induced. (c) The GST-4::GFP expression pattern in the xrep-1(k1007) mutants. Without
acrylamide, a GST signal is detected from the whole body. (d) MJCU047 wild-type xrep-1(+) animals. Without acrylamide, no GST-30::GFP expression is
detected (arrows). (e) MJCU047 wild-type xrep-1(+) animals treated with 500 mg/L acrylamide for 24 hours at 20uC. GST-30::GFP expression is
observed in the pharynx, hypodermis, and intestine. (f) The GST-30::GFP expression pattern in the xrep-1(k1007) mutants. GST-30::GFP expression is
detected from the pharynx, hypodermis, and intestine. Scale bars, 500 mm.
doi:10.1371/journal.pone.0011194.g001
Regulation of Phase II Enzymes
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11194body wall muscle (Figs. 3, S2). These results suggest that not all
acrylamide-induced GST-4 expression is under SKN-1 regulation.
XREP-1 negatively regulates GST expression
Because the xrep-1(k1007) mutation constitutively expresses GST
without acrylamide, we hypothesized that xrep-1 negatively regulated
GST-4 expression and that acrylamide triggered GST induction by
preventing normal XREP-1 function. To test this hypothesis, we first
constructed the xrep-1(+)::rfp fusion gene and transferred it into the
xrep-1(k1007) mutant. The xrep-1(+)::rfp completely rescued the xrep-
1(k1007) mutant phenotype, but XREP-1::RFP fluorescence was too
weak to be useful for the present experiment (data not shown).
Therefore, we used a strain, MJCU058 {unc-119(ed3) III, kIs15[gst-
4::rfp, gst-2::gfp, pDP#MM016B] IV}. This strain emitted no
detectable GST-4::RFP fluorescence signal, with a hardly detectable
weak constitutive GST-2::GFP signal from the mouth region (Fig.
S3a). Treatment of MJCU058 with acrylamide increased the RFP
signal, but did not change the GFP fluorescence signal (Fig. S3b). We
introduced the xrep-1(k1007) mutation into the strain MJCU058 to
construct MJCU059 {xrep-1(k1007) I; unc-119(ed3) III, kIs15 IV},
which, similarly to the fully induced GST-4::GFP expression pattern
of MJCU017, constitutively expressed a strong GST-4::RFP signal
from the whole body, without changing the level of the GST-2::GFP
signal (Fig. S3c).
We then constructed an xrep-1(+)::gfp fusion gene (Fig. 4a) and
introduced it into MJCU059 to obtain MJCU080 {kEx80[xrep-
1(+)::gfp, pRF4]; xrep-1(k1007) I; unc-119(ed3) III, kIs15 IV}. The
extrachromosomal array kEx80[xrep-1(+)::gfp, pRF4] of MJCU080
rescued the xrep-1(k1007) mutant phenotype and expressed GFP in
the cytoplasm and nuclei of neurons, somatic gonads, intestine,
and hypodermis over the whole body (Fig. 5). Because the
extrachromosomal array of MJCU080 was mitotically unstable,
Figure 2. Genetic mapping and cloning of the xrep-1 gene. (a) SNP mapping. The frequencies of Hawaiian polymorphism within F21C3, D2030,
and T23G11 were 6 /591 (also designated as 1 % HA), 0 /704 (0 % HA), and 1 /704 (0.1 % HA), respectively. RNAi of D2030.9 was performed with
MJCU017 by assaying the inducibility of GST-4 expression. Also, the genomic DNA fragment of D2030.9 was used to rescue the xrep-1(k1007) mutant
phenotype. (b) Deduced protein structure of XREP-1A (see also Figure 4a-2) and locations of the five mutations identified in the present study.
Amber-colored boxes represent seven WD40 domain repeats. DWD box indicates a DDB-1 (damaged DNA binding protein) WD40 binding domain.
The k1002 mutation changes CGT to CAT resulting in R to H substitution at position 342. The k1007 mutation changes TGG to TGA resulting in W to
protein chain termination at position 344. The k1011 mutation changes GAT to AAT resulting in D to N at position 312. The k1012 mutation changes
GGA to GAA resulting in G to E at position 331. The k1016 mutation changes TCA to TTA, resulting in S to L at position 448.
doi:10.1371/journal.pone.0011194.g002
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transgene. Interestingly, although expectedly, those cells or tissues
that retained the xrep-1(+)::gfp transgene, thus keeping the xrep-
1(k1007) under rescue, emitted GFP signals. In contrast, cells or
tissues without the xrep-1(+)::gfp transgene emitted no GFP signal,
thus displaying the xrep-1 mutant phenotype as expected; that is,
they emitted the RFP fluorescence signal (Figs. 5a–f). After a 48-
hour acrylamide treatment, however, even those cells or tissues
possessing xrep-1(+)::gfp that emitted the GFP signal were also
induced to emit RFP fluorescence (Figs. 5g–l). This mosaic analysis
confirmed our earlier hypothesis that XREP-1 repressed GST
from being expressed in the absence of acrylamide and de-
repressed GST expression in its presence.
Notably, when MJCU080 animals were treated with acrylamide
for 24 hours, the induction of GST expression was not so strong as
would be expected from strains such as MJCU017 (Figs. 6a–b).
Following 72 hours of acrylamide treatment, however, GST
expression was well induced (Fig. 6c). We interpret the result to
mean that this ‘‘super-repression’’ of acrylamide-induced GST
expression was caused by over-expression from extra copies of the
xrep-1(+)::gfp transgene. Its repression was eliminated when the
animals were treated with xrep-1(RNAi) (Figs. 6d–f). This result
further augments our hypothesis that XREP-1 controls GST
expression through negative regulation, which is responsive to and
inactivated or released by acrylamide. The XREP-1-mediated
regulation of GST expression agrees with some functional
evidence of this regulation: for instance, xrep-1(k1007) and xrep-
1(RNAi) animals show more resistance to aldicarb than do their
wild-type counterparts (manuscript in preparation).
We constructed the chromosomally-integrated stable Is line
MJCU085 {unc-119(ed3) III, kIs84[xrep-1(+)::gfp, pDP#MM016B]}
and confirmed that its expression pattern did not differ from that
for the Ex line MJCU080 (Fig. S4).
Functionality of complementary DNAs for two separate
xrep-1 gene transcripts
The xrep-1 gene is predicted to encode a few protein isoforms
according to WormBase (http://www.wormbase.org/). We ob-
tained two transcripts from N2 animals, which were then used to
synthesize xrep-1a and xrep-1b cDNAs. By sequencing them, we
found that xrep-1a cDNA comprises 10 exons (exons 1, 2, and 4 to
11 with exclusion of exon 3) and xrep-1b cDNA consists of 9 exons
(exons 3 to 11 with the exclusion of exons 1 and 2). Exons 4 to 11
were identical in both cDNAs except for the 9th exon; the 9th
exon in xrep-1b cDNA was 24 bp shorter than that in xrep-1a
(Fig. 4b). We then constructed xrep-1aProm acDNA::gfp and xrep-
1bProm bcDNA::gfp fusion genes (Fig. 4a), which were used to
transform MJCU059 {xrep-1(k1007) I; unc-119(ed3); kIs15 IV}, and
obtained at least two lines of transgenic animals for each fusion
gene. As observed with the xrep-1(+)::gfp transgene, xrep-1aProm
acDNA::gfp expressed GST-4 in a variety of organs, tissues, or cell
types in the body, such as pharynx, hypodermis, intestine, and
neurons (Fig. S4), and completely rescued the xrep-1(k1007)
mutant phenotype. GST-4 expression in the xrep-1aProm acD-
NA::gfp transgenic animal was not detected without acrylamide,
but was induced with acrylamide (Figs. 7a–b). In contrast, the xrep-
1bProm bcDNA::gfp transgene did not rescue the xrep-1(k1007)
phenotype (Fig. 7c), as GST-4 was expressed in the absence of
acrylamide (Fig. S4).
We then constructed other gfp fusion genes, xrep-1aProm
bcDNA::gfp and xrep-1aProm acDNAEx4-11::gfp (Fig. 4a); the former
was an xrep-1b cDNA::gfp fusion gene transcribed from the xrep-1a
start codon, whereas the latter was an xrep-1a cDNA::gfp fusion gene
without exons 1 through 3. Both fusion genes were then
introduced into MJCU059. These fusion genes exhibited the
same expression pattern as did the xrep-1aProm acDNA::gfp gene
(Fig. S4). Also the xrep-1aProm acDNAEx4-11::gfp fusion gene
completely rescued the xrep-1(k1007) phenotype (Figs. 7e–f);
however, the xrep-1aProm bcDNA::gfp did not (Fig. 7d).
Discussion
Of the phase II enzymes, GSTs are universally found in every
organism from bacteria to humans and constitute a large family of
enzymes that function as detoxifiers of both endogenous oxidative
stress products and exogenous electrophilic chemical compounds
[7–11]. Also very importantly, some GSTs are not just detoxifiers
but multifunctional performers, as they participate in steroid and
eicosanoid biosynthesis as well as in amino acid metabolism
[9,12,13]. The C. elegans genome contains 52 gst-coding genes in
the Alpha, Sigma, Omega, Zeta, and Pi classes (WormBase,
Figure 3. The xrep-1-induced GST-4 expression is partially regulated by the transcription factor SKN-1. The GST-4 expression pattern of
each RNAi in the xrep-1(k1007) mutant, without acrylamide (control) (a-c) or treated with 500 mg/L acrylamide (d-f). (a) Strong GFP signal is detected
from the whole body. (b) GST-4 expression is suppressed by gfp(RNAi) except for that in the pharynx. (c) GST-4 expression is suppressed by skn-
1(RNAi) except for that in the pharynx and body-wall muscle. (d) GST-4 expression is not further induced by acrylamide over that in the animals of a.
(e) GST-4 expression pattern suppressed by gfp(RNAi) is unaffected by acrylamide. (f) GST-4 expression pattern suppressed by skn-1(RNAi) is not
changed by acrylamide. Scale bars, 500 mm.
doi:10.1371/journal.pone.0011194.g003
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nently up-regulated when animals were treated with acrylamide
[11]. Because acrylamide is (a) found widely and abundantly in
various foods as a hazardous food contaminant, (b) known as a
potential carcinogen for humans, and (c) induces a large number
and variety of phase II enzymes, we have selected this chemical as
a model xenobiotic chemical probe that should represent a
substantial number of xenobiotic compounds [11,18,21,22,23]
(Fig. S5). To understand the genetic, molecular, and cellular
processes of xenobiotics, we have attempted to dissect genetically a
xenobiotics response pathway (xrep)i nC. elegans by isolating
mutants that respond abnormally to acrylamide. We have so far
found four xrep genes: three genes (xrep-1 I, -2 II, and -3 IV)
negatively and one gene (xrep-4 I) positively regulate GST
expression.
The negatively regulating gene xrep-1 encodes XREP-1, a
nematode homologue of the WD-repeat containing protein 23 or
WDR23. WDR exists in a broad range of organisms from yeasts to
mammals as well as plants. It participates in a variety of
biochemical, cellular, and organismal processes, such as signal
transduction, cytoskeletal dynamics, and RNA processing [19]. A
family of WDR proteins functions as a substrate adapter for
ubiquitin E3 ligase, and WDR domains are predicted to form a b-
propeller structure, which acts as a dock for interaction with other
proteins [19]. Another family of proteins predicted to form the b-
propeller structure is a group of proteins containing Kelch-repeat
domains, which are also considered to serve as substrate adaptors
for ubiquitin E3 ligase [19]. One such protein called Keap1
represses the bZIP transcription factor Nrf2 via the Kelch-repeat
domain for degradation through the ubiquitin-proteasome path-
way in the absence of oxidative or electrophilic stresses. In the
presence of such stresses, Nrf2 is freed from Keap1 into the
nucleus where it induces the expression of phase II enzymes
[8,24]. In C. elegans, the bZIP transcription factor SKN-1, which is
necessary for mesendodermal differentiation during early embryo-
genesis [25], is found to function similarly to Nrf2 by inducing
phase II enzyme expression in response to oxidative stresses
[26–30], sodium arsenite [30], and acrylamide [11]. According to
our transcriptome analysis, a large number of genes coding for
such detoxifying enzymes as GSTs, UGTs, and SDRs are
Figure 4. Structures of xrep-1 fusion constructs and partial DNA sequences of xrep-1 transcripts. (a) Structures of various xrep-1::gfp
fusion constructs. Two yellow boxes indicate exons 1 and 2 unique to xrep-1a, and a red box indicates exon 3 unique to xrep-1b. Black boxes indicate
5’ untranslated sequences, and a green box indicates gfp cDNA. The arrowhead indicates a shorter exon 9, whose sequence is shown in b. (b) Partial
DNA sequence alignment of xrep-1a cDNA (upper lines) and xrep-1b cDNA (lower lines). Exon 9 in xrep-1b cDNA was 24 bp shorter than that in xrep-
1a (arrowhead).
doi:10.1371/journal.pone.0011194.g004
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might control SKN-1, similarly to the mammalian Keap1 for Nfr2
operative in the so-called antioxidant response element (ARE)
pathway [9,31]. An idea similar to this was recently reported [20].
Indeed, RNAi knockdown of skn-1 prevented the xrep-1(k1007)
mutants and acrylamide-treated animals from expressing GST-4
in most parts of the C. elegans body, except for the pharynx and
body-wall muscle (Fig. 3). Because the RNAi knockdown of gfp did
not prevent GST-4 expression in the pharynx, however, we
assume that RNAi itself did not work in the pharynx. GST-4
expression was not further induced in the xrep-1(k1007) mutants
when they were treated with acrylamide (Fig. 3), thus suggesting
that all observed acrylamide-induced GST-4 expression was under
control through XREP-1. SKN-1 seemed to control GST-4
expression downstream of XREP-1 in the xenobiotics response
pathway, albeit in a tissue-specific fashion, as GST-4 was
expressed in the body-wall muscle of skn-1(RNAi) animals. All five
xrep-1 mutation sites so far identified are located in the WDR
domain of XREP-1 (Fig. 2). This result is consistent with the idea
that this domain may be important for interaction with SKN-1.
Here we have an emerging picture of a functional similarity
between the two pairs of proteins XREP-1/SKN-1 in worms and
Keap1/Nrf2 in mammals, as both play a key role in the oxidative
and electrophilic stress pathway. At the same time, however, this
leaves us with fascinating evolutionary puzzles: (a) how the two
counterparts XREP-1 and Keap1, considered as phylogenetically
distant relatives (19), have converged to assume essentially an
identical role in the pathway critically important in defending
organisms against oxidative, xenobiotic, or other life-threatening
stresses, (b) why or if really the nematode C. elegans lacks a
homologue of the mammalian Keap1, which exists also in
the insect Drosophila (32), and (c) why no or if any mammalian
WD40 repeat proteins play a role similar to that for the C. elegans
XREP-1.
We obtained two cDNAs, xrep-1a and xrep-1b, which were PCR
products of transcripts from the N2 wild type, and analyzed their
function. The xrep-1a cDNA consisting of the exons 4 to 11, which
corresponds to a C-terminus of 775 amino acid residues, was
sufficient to rescue the mutation xrep-1(k1007) and regulate
acrylamide-induced GST expression just as does the entire xrep-1
gene (Fig. 7). Contrarily, the xrep-1b cDNA showed none of these
functions. In the present experiment we could not detect any other
transcripts, as implicated in WormBase (http://www.wormbase.
org/). Thus, we have yet to know what the xrep-1b or any other
transcripts of the xrep-1 gene are doing.
In summary, with the aid of C. elegans genetics we have so far
identified four xrep genes that regulate the GST expression in the
xenobiotics response pathway, and introduced here one of them,
xrep-1. The gene xrep-1 that encodes a nematode homologue of
WDR23 negatively regulates a large number of phase II enzymes
[23]. Currently, we are studying our three remaining xrep genes
while continuing isolation of new Xrep mutants to understand the
Figure 5. Mosaic analysis for xrep-1 functions. (a, d) XREP-1::GFP mosaic expression pattern in MJCU080 {kEx80[xrep-1(+)::gfp, pRF4]; xrep-
1(k1007) I; unc-119(ed3) III; kIs15 IV} without acrylamide. (b, e) GST-4::RFP expression pattern in MJCU080 without acrylamide. (c, f) Merged image. The
xrep-1(k1007) phenotype is rescued in XREP-1::GFP-expressing cells or tissues. (g, j) XREP-1::GFP mosaic expression pattern in MJCU080, treated with
500 mg/L acrylamide. (h, k) GST-4::RFP expression pattern in MJCU080, treated with 500 mg/L acrylamide. (i, l) Merged image. GST-4::RFP expression
is also detected in XREP-1::GFP-expressing cells or tissues. Scale bars, a, b, c, g, h, i, 200 mm; d, e, f, j, k, l, 50 mm. The images d, e, f, j, k, l are the
respective enlargements of a, b, c, g, h, i. The images c, f, i, l are the respective merged images of a/b, d/e, g/h, j/k.
doi:10.1371/journal.pone.0011194.g005
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endogenous stress response pathways and their regulation.
Materials and Methods
Nematode culturing and strains
Nematode culturing and handling were carried out at 20uCa s
described by Brenner [33]. Strains used in this experiments were N2
(Bristol strain), CB4856 (Hawaiian polymorphic strain), CB61 dpy-
5(e61) I, CB1091 unc-13(e1091) I, CB120 unc-4(e120) II,C B 3 6 4dpy-
18(e364) III, DP38 unc-119(ed3) III, CB138 unc-24(e138) IV, CB270
unc-42(e270) V, CB678 lon-2(e678) X, MJCU017 {unc-119(ed3) III,
kIs17[gst-4::gfp, pDPMM#016B] X} [11], MJCU047 {unc-119(ed3)
III, kIs41[gst-30::gfp, pDPMM#016B] X}, and MJCU058 {unc-
119(ed3) III, kIs15[gst-4::rfp, gst-2::gfp, pDP#MM016B] IV}.N G M
plates containing 500 mg/L (about 7 mM) acrylamide were
prepared as described by Hasegawa et al. [11].
Strain construction
To make reporter constructs, all PCRs were performed with
KOD Plus DNA polymerase (TOYOBO, Osaka, Japan) on N2
genomic DNA. PCR primer sequences are listed in Table S1. A
fragment of C. elegans unc-54 39UTR region was obtained by
cutting the region with EcoRI and SpeI from the gfp vector
pPD95.77 (kindly provided by A. Fire, Stanford University) and
integrated into the equivalent restriction site of pDsRed-Monomer
(Clontech, CA, USA) for rfp (red fluorescence protein) vector
pMH06.12-Red. PCR primers for gst-2, gst-4, and gst-30 were
designed to amplify predicted promoters for each gene, about 1.2–
0.8 kbp upstream from the predicted start sites spanning over full
coding regions without the stop codons. PCR-amplified DNA
fragments were digested with the appropriate restriction enzymes
(Table S1) and ligated into the gfp vector pPD95.77 (for gst-2::gfp
and gst-30::gfp) or the rfp vector pMH06.12-Red (for gst-4::rfp).
Each reporter construct (100 mg/mL) so obtained was co-injected with
an equal concentration of pDP#MM016B into the gonadal arms of
unc-119(ed3) adult hermaphrodites [34,35] to obtain MJCU013 {unc-
119(ed3) III; kEx13[gst-4::rfp, gst-2::gfp, pDP#MM016B]} and
MJCU024 {unc-119(ed3) III; kEx24[gst-30::gfp, pDP#MM016B]}.E a c h
transgene’s extrachromosomal array was chromosomally integrated by
the method of Mitani [36], and transgenic animals thus obtained were
outcrossed at least three times with N2 to obtain MJCU058 {unc-
Figure 6. Extra copies of the xrep-1(+)::gfp transgene suppress acrylamide-induced GST-4::RFP expression. (a) Fluorescence plus bright
field images of MJCU080 {kEx80[xrep-1(+)::gfp, pRF4]; xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV}. Without acrylamide, no RFP signal is detected. (b)
Fluorescence plus bright field images of MJCU080, treated with 500 mg/L of acrylamide for 24 hours at 20uC. Weak RFP signal is detected. (c)
Fluorescence image of MJCU080, treated with 500 mg/L acrylamide for 72 hour at 20uC. RFP fluorescence signal is detected. (d) Fluorescence image
of MJCU080, treated with xrep-1(RNAi) and 500 mg/L of acrylamide for 24 hours at 20uC. RFP fluorescence signal is detected. (e) Fluorescence image
of MJCU080, treated with xrep-1(RNAi) for 24 hours at 20uC. RFP fluorescence signal is detected. (f) Fluorescence image of MJCU058 {unc-119(ed3) III;
kIs15 IV}, treated with xrep-1(RNAi) and 500 mg/L of acrylamide for 24 hours at 20uC. RFP fluorescence signal is detected. Scale bars, 500 mm.
doi:10.1371/journal.pone.0011194.g006
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MJCU047 {unc-119(ed3) III; kIs41[gst-30::gfp, pDPMM#016B] X}.
Linkage mapping with the conventional markers (listed in the sub-
section Nematode culturing and strains) located the fusion gene gst-
4::rfp, gst-2::gfp of MJCU058 integrated in the linkage group IV and,
similarly, the fusion gene gst-30::gfp of MJCU047inX (datanotshown).
By the standard genetic methods, xrep-1(k1007) was transferred into
MJCU058 {unc-119(ed3) III; kIs15 IV} to construct MJCU059 {xrep-
1(k1007) I; unc-119(ed3) III; kIs15 IV}. Fluorescence expression patterns
were observed with a Nikon SMZ800 dissection microscope equipped
with a fluorescence filter.
Mutant isolation and mapping
We mutagenized the transgenic strains MJCU017 and
MJCU047 with 50 mM ethyl methanesulfonate (EMS), follow-
ing essentially the method described by Brenner [33] to obtain
mutants expressing GST abnormally. Twenty-four mutants
obtained independently were outcrossed at least three times with
N2 wild type to reduce extraneous mutations. By complemen-
tation testing, 16 of 24 mutants were grouped as the same gene
xrep-1. The allele xrep-1(k1007) was first mapped to linkage
group I by using conventional markers, dpy-5(e61) I, unc-4(e120)
II, dpy-18(e364) III, unc-24(e138) IV, unc-42(e270) V, lon-2(e678)
X, and their positions were then narrowed by single-nucleotide
polymorphism mapping [37]. We defined a genomic region
between the SNP markers F21C3 and T23G11. No Hawaiian
polymorphism was found within D2030 (total 704 recombinants
inquired) indicating that the mutation site was nearby or within
the cosmid clone D2030. We amplified 12 genes within D2030
with T7 promoter-added primers and synthesized dsRNA for
soaking RNAi [38]. From the soaking RNAi results, the
candidate gene D2030.9 was selected, PCR-amplified from the
N2 wild-type genomic DNA, and co-injected with the pRF4
marker DNA into mutant animals following the method by
Mello et al. [34].
xrep-1::gfp fusion gene construction
Five different gfp fusion genes, xrep-1(+)::gfp, xrep-1aProm
acDNA::gfp, xrep-1bProm bcDNA::gfp, xrep-1aProm bcDNA::gfp, and
xrep-1aProm acDNAEx4-11::gfp, were constructed. PCR primer
sequences are listed in Table S2. The predicted xrep-1 promoter
(2,110 bp upstream from the predicted start site) plus the deduced
coding region was amplified with the primers XREP-1abp_Hin-
dIII_For and XREP-1ab_BamHI_Rev (Table S2) by PCR from
the N2 genomic DNA and ligated into the pPD95.77 gfp
expression vector to obtain the xrep-1(+)::gfp construct. Two
isoforms of xrep-1 cDNA, xrep-1a and xrep-1b, were each amplified
with the primers XREP-1ap_cDNA_For and XREP-1ab_Bam-
HI_Rev (xrep-1a cDNA) or XREP-1bp_cDNA_For and XREP-
1ab_BamHI_Rev (xrep-1b cDNA) (Table S2) by PCR from the two
isoformic N2 cDNAs as templates originally derived from two
respective transcripts. The xrep-1a or xrep-1b promoter was
amplified with the primers XREP-1abp_HindIII_For and
XREP-1ap_cDNA_Rev (xrep-1a promoter) or XREP-1abp_Hin-
dIII_For and XREP-1bp_cDNA_Rev (xrep-1b promoter) (Table
S2) by PCR from the N2 genomic DNA. Either xrep-1a promoter
and xrep-1a cDNA or xrep-1b promoter and xrep-1b cDNA were
connected and ligated into the pPD95.77 gfp expression vector to
obtain the xrep-1aProm acDNA::gfp or xrep-1bProm bcDNA::gfp
construct (Figure 4a). Next, xrep-1b cDNA, connected to the xrep-
1a promoter, was ligated into the pPD95.77 to obtain xrep-1aProm
bcDNA::gfp (Figure 4a).
Figure 7. Expression patterns of xrep-1 cDNA::gfp fusion genes in the xrep-1(k1007) background. GFP represents XREP-1 expression and
RFP indicates GST-4 expression, without (a, c, d, e) or with 500 mg/L of acrylamide (b, f). (a) Fluorescence image of MJCU086. xrep-1aProm acDNA::gfp
completely rescues xrep-1(k1007) GST-4::RFP expression. (b) Fluorescence image of MJCU086. After acrylamide treatment xrep-1aProm acDNA::gfp
induces GST-4::RFP expression normally. (c) Fluorescence image of MJCU088. xrep-1bProm bcDNA::gfp does not rescue k1007 GST-4::RFP expression.
(d) Fluorescence image of MJCU097. xrep-1aProm bcDNA::gfp does not rescue k1007 GST-4::RFP expression. (e) Fluorescence image of MJCU091. xrep-
1aProm acDNAEx4-11::gfp completely rescues GST-4::RFP expression. (f) Fluorescence image of MJCU091. After acrylamide treatment xrep-1aProm
acDNAEx4-11::gfp induces GST-4::RFP expression normally. Anterior is left, scale bars 200 mm.
doi:10.1371/journal.pone.0011194.g007
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amplified with the primers XREP-1ap_Exon4-11_For and XREP-
1ab_BamHI_Rev (Table S2) from the N2 cDNA derived from the
xrep-1a transcript. Again the xrep-1a promoter was amplified with
primers XREP-1abp_HindIII_For and XREP-1ap_Exon4-
11_Rev (Table S2) from the N2 genomic DNA and connected
with the xrep-1a cDNA exon 4 to 11 and ligated into the pPD95.77
gfp expression vector to obtain xrep-1aProm acDNAEx4-11::gfp
(Figure 4a). One hundred mg/mL of each reporter construct so
obtained was co-injected with an equal concentration of
pDP#MM016B or pRF4 into the gonadal arms of unc-119(ed3)
or MJCU059 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV} adult
hermaphrodites as described [34,35]. Integration of transgenic
extrachromosomal arrays into chromosomes was performed as
described by Mitani [36], and integrated lines were outcrossed two
times with N2 wild type. Transgenic animals so obtained were
MJCU080 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV; kEx80[xrep-
1(+)::gfp, pRF4]}, MJCU081 {xrep-1(k1007) I; unc-119(ed3) III;
kIs15 IV; kEx81[xrep-1(+)::gfp, pRF4]}, MJCU085 {unc-119(ed3) III;
kIs84[xrep-1(+)::gfp, pDP#MM016B]}, MJCU086 {xrep-1(k1007) I;
unc-119(ed3) III; kIs15 IV; kEx86[xrep-1aProm acDNA::gfp, pRF4]},
MJCU087 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV; kEx87[xrep-
1aProm acDNA::gfp, pRF4]}, MJCU088 {xrep-1(k1007) I; unc-
119(ed3) III; kIs15 IV; kEx88[xrep-1bProm bcDNA::gfp, pRF4]},
MJCU089 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV; kEx89[x-
rep-1bProm bcDNA::gfp, pRF4]}, MJCU091 {xrep-1(k1007) I; unc-
119(ed3) III; kIs15 IV; kEx91[xrep-1aProm acDNAEx4-11::gfp,
pRF4]}, MJCU094 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV;
kEx94[xrep-1aProm acDNAEx4-11::gfp, pRF4]}, MJCU097 {xrep-
1(k1007) I; unc-119(ed3) III; kIs15 IV; kEx97[xrep-1aPromb cDNA::gfp,
pRF4]}, and MJCU098 {xrep-1(k1007) I; unc-119(ed3) III; kIs15 IV;
kEx98[xrep-1a Prom bcDNA::gfp, pRF4]}.
RNAi
Gene fragments of skn-1 cDNA, xrep-1 cDNAEx4-11, or gfp
were prepared by PCR amplification of C. elegans N2 cDNA,
genomic DNA, or plasmid vector pPD95.77, respectively, with
primers (Table S3). Each PCR fragment was digested with EcoRI
and cloned into the EcoRI restriction site of the RNAi vector
pPD129.36 (kindly provided by A. Fire, Stanford University). The
PCR fragment-ligated plasmid or the blank vector pPD129.36 was
used to transform E. coli HT115 [39].
For RNAi experiments, synchronized L1-stage animals were
first cultured for 48 hours at 20uC on NGM (containing 50 mg/
mL ampicillin and 12.5 mg/mL tetracycline) plates seeded with E.
coli HT115 transformed with each different RNAi plasmid. The
animals were then collected and transferred onto NGM plates with
or without 500 mg/L acrylamide, seeded with each different E. coli
HT115 RNAi bacteria. After 24 to 48 hours of incubation, the
animals were observed for GFP expression with both a Nikon
SMZ800 dissection microscope equipped with a fluorescence filter
and a ZEISS Axiovert 200 microscope equipped with a confocal
laser-scanning module.
Supporting Information
Figure S1 GST-4 expression is induced when the transgenic
MJCU017 animals are treated with soaking RNAi of D2020.9
(xrep-1). (a) MJCU017 animals treated with blank RNAi. No GST-
4::GFP expression is detected (arrows point to three animals). (b)
MJCU017 animals treated with xrep-1(RNAi). GST-4::GFP
expression is induced. Scale bar, 500 mm.
Found at: doi:10.1371/journal.pone.0011194.s001 (1.29 MB TIF)
Figure S2 GST-4 expression induced by acrylamide and xrep-
1(k1007) mutation is prevented by skn-1(RNAi) except for that in
the pharynx and body-wall muscle. (a-c) GST-4 expression
patterns in MJCU017 treated with 500 mg/L acrylamide. (d-f)
GST-4 expression patterns in xrep-1(k1007) without acrylamide.
(g-i) GST-4 expression patterns of skn-1(RNAi) in xrep-1(k1007)
without acrylamide. Scale bars, 50 mm.
Found at: doi:10.1371/journal.pone.0011194.s002 (1.33 MB TIF)
Figure S3 (a) Fluorescence plus bright field images of MJCU058
{unc-119(ed3) III; kIs15[gst-4::rfp, gst-2::gfp, pDP#MM016B] IV}.
Without acrylamide, no fluorescence signal is detected. (b)
Fluorescence image of MJCU058, treated with 500 mg/L of
acrylamide at 20uC for 24 hours. RFP fluorescence signal is
detected. (c) Fluorescence image of MJCU059 {xrep-1(k1007) I;
unc-119(ed3) III; kIs15 IV}. RFP fluorescence signal is detected. (d-
f) RFP fluorescence signal in the MJCU058 {unc-119(ed3) III; kIs15
IV} animal, treated with 500 mg/L of acrylamide at 20uC for
24 hours. (d) Head. (e) Vulva. (f) Tail. Scale bars, a-c, 500 mm; d-f,
50 mm.
Found at: doi:10.1371/journal.pone.0011194.s003 (2.14 MB TIF)
Figure S4 Expression patterns of various xrep-1::gfp fusion genes.
(a-c) XREP-1::GFP expression. (d-f) XREP-1aProm acDNA::GFP
expression. (g-i) XREP-1bProm bcDNA::GFP expression patterns.
(j-l) XREP-1aProm bcDNA::GFP expression. (m-o) XREP-
1aProm acDNAEx4-11::GFP expression. Scale bars, 50 mm.
Found at: doi:10.1371/journal.pone.0011194.s004 (1.79 MB TIF)
Figure S5 GST and UGT responses in transgenic animals against
several xenobiotics. Young adult transgenics were transferred into
NGM plates containing each xenobiotic and incubated at 25uCf o r
24 hours. Transgenic animals used in these experiments were
MJCU017 {unc-119(ed3) III; kIs17[gst-4::gfp, pDP#MM016B] X},
MJCU028 {unc-119(ed3) III; kEx28[gsto-2b::cfp, pDP#MM016B]}
(23), MJCU003 {kEx3[gst-7::gfp, pRF4]} (11), MJCU047 {unc-
119(ed3) III; kIs41[gst-30::gfp, pDP#MM016B] X}, and MJCU050
{unc-119(ed3) III; kIs20[ugt-13p::gfp, pDP#MM016B] III} (21).
Control, without xenobiotics; MeHg (500 nM Methylmercury);
Paraquat (20 mM Paraquat); tBOOH (1 mM tert-Butyl hydroperox-
ide); AA (7 mM Acrylamide). (a) GST-4::GFP expression was not
detected. Arrows indicate animals. (b) GST-4::GFP expression was
induced when animals were treated with MeHg. (c) GST-4::GFP
expression was slightly induced (arrows) when animals were treated
with paraquat. (d) GST-4::GFP expression was induced when
animals were treated with tBOOH. (f) Weak GSTO-2B::CFP
expression was detected. (g-i) GSTO-2B::CFP expression was
induced when animals were treated with MeHg, paraquat, and
tBOOH. (k) Weak GST-7::GFP expression was detected. (l-n) GST-
7::GFP expression was induced when animals were treated with
MeHg, paraquat, and tBOOH. (p) GST-30::GFP expression was not
detected. Arrows indicate animals. (q) GST-30::GFP expression was
induced when animals were treated with MeHg (arrows). (r) GST-
30::GFP expression was not induced when animals (arrows) were
treated with paraquat. (s) GST-30::GFP expression was induced
when animals were treated with tBOOH (arrows). (u) Weak UGT-
13::GFP expression was detected. (v-x) UGT-13::GFP expression was
induced when animals were treated with MeHg, paraquat, and
t B O O H .( e ,j ,o ,t ,y )A l lo ft h eG S T -a n dU G T - f u s e dG F P
expressions were strongly induced when animals were treated with
AA (11). Scale bars, 500 mm.
Found at: doi:10.1371/journal.pone.0011194.s005 (1.64 MB TIF)
Table S1 Primers for gst::reporter fusion genes.
Found at: doi:10.1371/journal.pone.0011194.s006 (0.02 MB
DOC)
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Found at: doi:10.1371/journal.pone.0011194.s007 (0.02 MB
DOC)
Table S3 Primers for RNAi.
Found at: doi:10.1371/journal.pone.0011194.s008 (0.02 MB
DOC)
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